Ribosomal protein L17 pseudogene 34 (RPL17P34)

The locus referred to as RPL17P34 is a pseudogene of ribosomal protein L17[1][2][4]. Ribosomal protein pseudogenes arise through duplication or retrotransposition events and do not produce functional proteins[13]. The functional RPL17 gene encodes a protein of the large 60S ribosomal subunit, involved in protein synthesis and associated with disorders such as Diamond-Blackfan anemia when mutated[3][5][9][15]. However, RPL17P34 (and other such pseudogenes) have no evidence of protein coding, do not participate in ribosome assembly/function, and are typically not expressed at meaningful levels[13]. These loci are not therapeutic targets, biomarkers, nor safety concerns, and their annotation yields null results for drug interactions or disease associations. Notes on correctness: - RPL17P34 is frequently confused with the genuine, protein-coding RPL17 gene[3][9], but it does not code for a functional protein, making its inclusion as a target incorrect in most scientific or therapeutic contexts. - No structured, functional, or clinical roles have been attributed to RPL17P34 in available scientific databases or literature[13][1][2][4]. - Product listings and database entries for RPL17P34 are catalog references for research reagents, not functional gene targets[1][2][4]. Summary: RPL17P34 represents a processed pseudogene, not a functional gene or therapeutic target, and has no established biological function, disease role, drug interactions, or clinical relevance in monitoring or safety. The entry should be flagged as incorrect if used in the context of actual molecular targets, and its only aliases are catalog or pseudogene references.

Other names

RPL17_10_1081RPL17P34